{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T19:52:04Z","timestamp":1789501924940,"version":"build-2803163510"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T00:00:00Z","timestamp":1656460800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T00:00:00Z","timestamp":1656460800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NS047384"],"award-info":[{"award-number":["NS047384"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NS122316"],"award-info":[{"award-number":["NS122316"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Molecular Autism"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Fragile X syndrome (FXS), the most common genetic cause of autism spectrum disorder and intellectual disability, is caused by the lack of fragile X mental retardation protein (FMRP) expression. FMRP is an mRNA binding protein with functions in mRNA transport, localization, and translational control. In\n                      <jats:italic>Fmr1<\/jats:italic>\n                      knockout mice\n                      <jats:italic>,<\/jats:italic>\n                      dysregulated translation has been linked to pathophysiology, including abnormal synaptic function and dendritic morphology, and autistic-like behavioral phenotypes. The role of FMRP in morphology and function of excitatory neurons has been well studied in mice lacking\n                      <jats:italic>Fmr1<\/jats:italic>\n                      , but the impact of\n                      <jats:italic>Fmr1<\/jats:italic>\n                      deletion on inhibitory neurons remains less characterized. Moreover, the contribution of FMRP in different cell types to FXS pathophysiology is not well defined. We sought to characterize whether FMRP loss in parvalbumin or somatostatin-expressing neurons results in FXS-like deficits in mice.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We used Cre-lox recombinase technology to generate two lines of conditional knockout mice lacking FMRP in either parvalbumin or somatostatin-expressing cells and carried out a battery of behavioral tests to assess motor function, anxiety, repetitive, stereotypic, social behaviors, and learning and memory. In addition, we used fluorescent non-canonical amino acid tagging along with immunostaining to determine whether de novo protein synthesis is dysregulated in parvalbumin or somatostatin-expressing neurons.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      De novo protein synthesis was elevated in hippocampal parvalbumin and somatostatin-expressing inhibitory neurons in\n                      <jats:italic>Fmr1<\/jats:italic>\n                      knockout mice. Cell type-specific deletion of\n                      <jats:italic>Fmr1<\/jats:italic>\n                      in parvalbumin-expressing neurons resulted in anxiety-like behavior, impaired social behavior, and dysregulated de novo protein synthesis. In contrast, deletion of\n                      <jats:italic>Fmr1<\/jats:italic>\n                      in somatostatin-expressing neurons did not result in behavioral abnormalities and did not significantly impact de novo protein synthesis. This is the first report of how loss of FMRP in two specific subtypes of inhibitory neurons is associated with distinct FXS-like abnormalities.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Limitations<\/jats:title>\n                    <jats:p>The mouse models we generated are limited by whole body knockout of FMRP in parvalbumin or somatostatin-expressing cells and further studies are needed to establish a causal relationship between cellular deficits and FXS-like behaviors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our findings indicate a cell type-specific role for FMRP in parvalbumin-expressing neurons in regulating distinct behavioral features associated with FXS.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13229-022-00509-2","type":"journal-article","created":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T09:04:58Z","timestamp":1656493498000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Deletion of Fmr1 in parvalbumin-expressing neurons results in dysregulated translation and selective behavioral deficits associated with fragile X syndrome"],"prefix":"10.1186","volume":"13","author":[{"given":"Magdalena","family":"Kalinowska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathijs B.","family":"van der Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Kitiashvili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maggie","family":"Mamcarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauricio M.","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Longo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7379-6802","authenticated-orcid":false,"given":"Eric","family":"Klann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,29]]},"reference":[{"key":"509_CR1","doi-asserted-by":"publisher","first-page":"17065","DOI":"10.1038\/nrdp.2017.65","volume":"3","author":"RJ Hagerman","year":"2017","unstructured":"Hagerman RJ, Berry-Kravis E, Hazlett HC, Bailey DB Jr, Moine H, Kooy RF, et al. Fragile X syndrome. Nat Rev Dis Primers. 2017;3:17065.","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"509_CR2","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s11689-020-09310-9","volume":"12","author":"KA Razak","year":"2020","unstructured":"Razak KA, Dominick KC, Erickson CA. Developmental studies in fragile X syndrome. J Neurodev Disord. 2020;12(1):13.","journal-title":"J Neurodev Disord"},{"issue":"Suppl 3","key":"509_CR3","doi-asserted-by":"publisher","first-page":"S194","DOI":"10.1542\/peds.2016-1159F","volume":"139","author":"WE Kaufmann","year":"2017","unstructured":"Kaufmann WE, Kidd SA, Andrews HF, Budimirovic DB, Esler A, Haas-Givler B, et al. Autism spectrum disorder in fragile X syndrome: cooccurring conditions and current treatment. Pediatrics. 2017;139(Suppl 3):S194\u2013206.","journal-title":"Pediatrics"},{"issue":"3","key":"509_CR4","doi-asserted-by":"publisher","first-page":"145","DOI":"10.5582\/irdr.2016.01048","volume":"5","author":"R Lozano","year":"2016","unstructured":"Lozano R, Azarang A, Wilaisakditipakorn T, Hagerman RJ. Fragile X syndrome: a review of clinical management. Intractable Rare Dis Res. 2016;5(3):145\u201357.","journal-title":"Intractable Rare Dis Res"},{"key":"509_CR5","doi-asserted-by":"publisher","first-page":"104740","DOI":"10.1016\/j.nbd.2020.104740","volume":"136","author":"MJ Salcedo-Arellano","year":"2020","unstructured":"Salcedo-Arellano MJ, Dufour B, McLennan Y, Martinez-Cerdeno V, Hagerman R. Fragile X syndrome and associated disorders: clinical aspects and pathology. Neurobiol Dis. 2020;136:104740.","journal-title":"Neurobiol Dis"},{"issue":"7429","key":"509_CR6","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/nature11737","volume":"492","author":"M Ascano Jr","year":"2012","unstructured":"Ascano M Jr, Mukherjee N, Bandaru P, Miller JB, Nusbaum JD, Corcoran DL, et al. FMRP targets distinct mRNA sequence elements to regulate protein expression. Nature. 2012;492(7429):382\u20136.","journal-title":"Nature"},{"issue":"Pt A","key":"509_CR7","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.brainres.2018.04.008","volume":"1693","author":"A Banerjee","year":"2018","unstructured":"Banerjee A, Ifrim MF, Valdez AN, Raj N, Bassell GJ. Aberrant RNA translation in fragile X syndrome: from FMRP mechanisms to emerging therapeutic strategies. Brain Res. 2018;1693(Pt A):24\u201336.","journal-title":"Brain Res"},{"issue":"11","key":"509_CR8","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1038\/nn.3379","volume":"16","author":"JC Darnell","year":"2013","unstructured":"Darnell JC, Klann E. The translation of translational control by FMRP: therapeutic targets for FXS. Nat Neurosci. 2013;16(11):1530\u20136.","journal-title":"Nat Neurosci"},{"issue":"2","key":"509_CR9","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.cell.2011.06.013","volume":"146","author":"JC Darnell","year":"2011","unstructured":"Darnell JC, Van Driesche SJ, Zhang C, Hung KY, Mele A, Fraser CE, et al. FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism. Cell. 2011;146(2):247\u201361.","journal-title":"Cell"},{"issue":"2","key":"509_CR10","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.neuron.2012.04.009","volume":"74","author":"I Iossifov","year":"2012","unstructured":"Iossifov I, Ronemus M, Levy D, Wang Z, Hakker I, Rosenbaum J, et al. De novo gene disruptions in children on the autistic spectrum. Neuron. 2012;74(2):285\u201399.","journal-title":"Neuron"},{"issue":"4","key":"509_CR11","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/jcbfm.2012.205","volume":"33","author":"M Qin","year":"2013","unstructured":"Qin M, Schmidt KC, Zametkin AJ, Bishu S, Horowitz LM, Burlin TV, et al. Altered cerebral protein synthesis in fragile X syndrome: studies in human subjects and knockout mice. J Cereb Blood Flow Metab. 2013;33(4):499\u2013507.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"10","key":"509_CR12","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/nrn4001","volume":"16","author":"JD Richter","year":"2015","unstructured":"Richter JD, Bassell GJ, Klann E. Dysregulation and restoration of translational homeostasis in fragile X syndrome. Nat Rev Neurosci. 2015;16(10):595\u2013605.","journal-title":"Nat Rev Neurosci"},{"issue":"6","key":"509_CR13","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/nm.4335","volume":"23","author":"I Gantois","year":"2017","unstructured":"Gantois I, Khoutorsky A, Popic J, Aguilar-Valles A, Freemantle E, Cao R, et al. Metformin ameliorates core deficits in a mouse model of fragile X syndrome. Nat Med. 2017;23(6):674\u20137.","journal-title":"Nat Med"},{"issue":"7375","key":"509_CR14","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/nature10658","volume":"480","author":"BD Auerbach","year":"2011","unstructured":"Auerbach BD, Osterweil EK, Bear MF. Mutations causing syndromic autism define an axis of synaptic pathophysiology. Nature. 2011;480(7375):63\u20138.","journal-title":"Nature"},{"issue":"2","key":"509_CR15","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.neuron.2012.07.022","volume":"76","author":"A Bhattacharya","year":"2012","unstructured":"Bhattacharya A, Kaphzan H, Alvarez-Dieppa AC, Murphy JP, Pierre P, Klann E. Genetic removal of p70 S6 kinase 1 corrects molecular, synaptic, and behavioral phenotypes in fragile X syndrome mice. Neuron. 2012;76(2):325\u201337.","journal-title":"Neuron"},{"issue":"11","key":"509_CR16","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1038\/nm.3353","volume":"19","author":"T Udagawa","year":"2013","unstructured":"Udagawa T, Farny NG, Jakovcevski M, Kaphzan H, Alarcon JM, Anilkumar S, et al. Genetic and acute CPEB1 depletion ameliorate fragile X pathophysiology. Nat Med. 2013;19(11):1473\u20137.","journal-title":"Nat Med"},{"issue":"7432","key":"509_CR17","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/nature11628","volume":"493","author":"CG Gkogkas","year":"2013","unstructured":"Gkogkas CG, Khoutorsky A, Ran I, Rampakakis E, Nevarko T, Weatherill DB, et al. Autism-related deficits via dysregulated eIF4E-dependent translational control. Nature. 2013;493(7432):371\u20137.","journal-title":"Nature"},{"issue":"7432","key":"509_CR18","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/nature11782","volume":"493","author":"E Santini","year":"2013","unstructured":"Santini E, Huynh TN, MacAskill AF, Carter AG, Pierre P, Ruggero D, et al. Exaggerated translation causes synaptic and behavioural aberrations associated with autism. Nature. 2013;493(7432):411\u20135.","journal-title":"Nature"},{"issue":"36","key":"509_CR19","doi-asserted-by":"publisher","first-page":"18060","DOI":"10.1073\/pnas.1908126116","volume":"116","author":"S Wiebe","year":"2019","unstructured":"Wiebe S, Nagpal A, Truong VT, Park J, Skalecka A, He AJ, et al. Inhibitory interneurons mediate autism-associated behaviors via 4E-BP2. Proc Natl Acad Sci U S A. 2019;116(36):18060\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"509_CR20","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1002\/dneu.20853","volume":"71","author":"B Rudy","year":"2011","unstructured":"Rudy B, Fishell G, Lee S, Hjerling-Leffler J. Three groups of interneurons account for nearly 100% of neocortical GABAergic neurons. Dev Neurobiol. 2011;71(1):45\u201361.","journal-title":"Dev Neurobiol"},{"issue":"7483","key":"509_CR21","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1038\/nature12983","volume":"505","author":"A Kepecs","year":"2014","unstructured":"Kepecs A, Fishell G. Interneuron cell types are fit to function. Nature. 2014;505(7483):318\u201326.","journal-title":"Nature"},{"issue":"1","key":"509_CR22","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41593-019-0551-8","volume":"23","author":"D Scheggia","year":"2020","unstructured":"Scheggia D, Manago F, Maltese F, Bruni S, Nigro M, Dautan D, et al. Somatostatin interneurons in the prefrontal cortex control affective state discrimination in mice. Nat Neurosci. 2020;23(1):47\u201360.","journal-title":"Nat Neurosci"},{"issue":"7501","key":"509_CR23","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nature13258","volume":"509","author":"SB Wolff","year":"2014","unstructured":"Wolff SB, Grundemann J, Tovote P, Krabbe S, Jacobson GA, Muller C, et al. Amygdala interneuron subtypes control fear learning through disinhibition. Nature. 2014;509(7501):453\u20138.","journal-title":"Nature"},{"issue":"3","key":"509_CR24","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.nbd.2005.08.019","volume":"21","author":"EJ Mientjes","year":"2006","unstructured":"Mientjes EJ, Nieuwenhuizen I, Kirkpatrick L, Zu T, Hoogeveen-Westerveld M, Severijnen L, et al. The generation of a conditional Fmr1 knock out mouse model to study Fmrp function in vivo. Neurobiol Dis. 2006;21(3):549\u201355.","journal-title":"Neurobiol Dis"},{"issue":"5","key":"509_CR25","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/j.neuron.2008.09.037","volume":"60","author":"CA Hoeffer","year":"2008","unstructured":"Hoeffer CA, Tang W, Wong H, Santillan A, Patterson RJ, Martinez LA, et al. Removal of FKBP12 enhances mTOR-Raptor interactions, LTP, memory, and perseverative\/repetitive behavior. Neuron. 2008;60(5):832\u201345.","journal-title":"Neuron"},{"key":"509_CR26","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.nbd.2015.08.016","volume":"83","author":"TN Huynh","year":"2015","unstructured":"Huynh TN, Shah M, Koo SY, Faraud KS, Santini E, Klann E. eIF4E\/Fmr1 double mutant mice display cognitive impairment in addition to ASD-like behaviors. Neurobiol Dis. 2015;83:67\u201374.","journal-title":"Neurobiol Dis"},{"issue":"6","key":"509_CR27","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/j.neuron.2007.12.001","volume":"56","author":"G Dolen","year":"2007","unstructured":"Dolen G, Osterweil E, Rao BS, Smith GB, Auerbach BD, Chattarji S, et al. Correction of fragile X syndrome in mice. Neuron. 2007;56(6):955\u201362.","journal-title":"Neuron"},{"issue":"Suppl 1","key":"509_CR28","doi-asserted-by":"publisher","first-page":"S55","DOI":"10.21037\/tp.2019.09.09","volume":"9","author":"H Hodges","year":"2020","unstructured":"Hodges H, Fealko C, Soares N. Autism spectrum disorder: definition, epidemiology, causes, and clinical evaluation. Transl Pediatr. 2020;9(Suppl 1):S55\u201365.","journal-title":"Transl Pediatr"},{"issue":"2","key":"509_CR29","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1523\/JNEUROSCI.3696-09.2010","volume":"30","author":"A Sharma","year":"2010","unstructured":"Sharma A, Hoeffer CA, Takayasu Y, Miyawaki T, McBride SM, Klann E, et al. Dysregulation of mTOR signaling in fragile X syndrome. J Neurosci. 2010;30(2):694\u2013702.","journal-title":"J Neurosci"},{"issue":"4","key":"509_CR30","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/ng0893-335","volume":"4","author":"D Devys","year":"1993","unstructured":"Devys D, Lutz Y, Rouyer N, Bellocq JP, Mandel JL. The FMR-1 protein is cytoplasmic, most abundant in neurons and appears normal in carriers of a fragile X premutation. Nat Genet. 1993;4(4):335\u201340.","journal-title":"Nat Genet"},{"issue":"5","key":"509_CR31","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1523\/JNEUROSCI.17-05-01539.1997","volume":"17","author":"Y Feng","year":"1997","unstructured":"Feng Y, Gutekunst CA, Eberhart DE, Yi H, Warren ST, Hersch SM. Fragile X mental retardation protein: nucleocytoplasmic shuttling and association with somatodendritic ribosomes. J Neurosci. 1997;17(5):1539\u201347.","journal-title":"J Neurosci"},{"issue":"10","key":"509_CR32","doi-asserted-by":"publisher","first-page":"5395","DOI":"10.1073\/pnas.94.10.5395","volume":"94","author":"IJ Weiler","year":"1997","unstructured":"Weiler IJ, Irwin SA, Klintsova AY, Spencer CM, Brazelton AD, Miyashiro K, et al. Fragile X mental retardation protein is translated near synapses in response to neurotransmitter activation. Proc Natl Acad Sci U S A. 1997;94(10):5395\u2013400.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"509_CR33","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1002\/cne.24100","volume":"525","author":"DA Zorio","year":"2017","unstructured":"Zorio DA, Jackson CM, Liu Y, Rubel EW, Wang Y. Cellular distribution of the fragile X mental retardation protein in the mouse brain. J Comp Neurol. 2017;525(4):818\u201349.","journal-title":"J Comp Neurol"},{"issue":"3","key":"509_CR34","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1093\/cercor\/bhz141","volume":"30","author":"JW Lovelace","year":"2020","unstructured":"Lovelace JW, Rais M, Palacios AR, Shuai XS, Bishay S, Popa O, et al. Deletion of Fmr1 from forebrain excitatory neurons triggers abnormal cellular, EEG, and behavioral phenotypes in the auditory cortex of a mouse model of fragile X syndrome. Cereb Cortex. 2020;30(3):969\u201388.","journal-title":"Cereb Cortex"},{"issue":"27","key":"509_CR35","doi-asserted-by":"publisher","first-page":"7079","DOI":"10.1523\/JNEUROSCI.1069-16.2016","volume":"36","author":"H Higashimori","year":"2016","unstructured":"Higashimori H, Schin CS, Chiang MS, Morel L, Shoneye TA, Nelson DL, et al. Selective deletion of astroglial FMRP dysregulates glutamate transporter GLT1 and contributes to fragile X syndrome phenotypes in vivo. J Neurosci. 2016;36(27):7079\u201394.","journal-title":"J Neurosci"},{"issue":"2","key":"509_CR36","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.biopsych.2016.08.036","volume":"82","author":"JL Hodges","year":"2017","unstructured":"Hodges JL, Yu X, Gilmore A, Bennett H, Tjia M, Perna JF, et al. Astrocytic contributions to synaptic and learning abnormalities in a mouse model of Fragile X syndrome. Biol Psychiatry. 2017;82(2):139\u201349.","journal-title":"Biol Psychiatry"},{"key":"509_CR37","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1100\/tsw.2006.220","volume":"6","author":"M Bernardet","year":"2006","unstructured":"Bernardet M, Crusio WE. Fmr1 KO mice as a possible model of autistic features. Sci World J. 2006;6:1164\u201376.","journal-title":"Sci World J"},{"key":"509_CR38","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.bbr.2014.05.046","volume":"271","author":"Q Ding","year":"2014","unstructured":"Ding Q, Sethna F, Wang H. Behavioral analysis of male and female Fmr1 knockout mice on C57BL\/6 background. Behav Brain Res. 2014;271:72\u20138.","journal-title":"Behav Brain Res"},{"issue":"8","key":"509_CR39","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1093\/hmg\/9.8.1145","volume":"9","author":"AM Peier","year":"2000","unstructured":"Peier AM, McIlwain KL, Kenneson A, Warren ST, Paylor R, Nelson DL. (Over)correction of FMR1 deficiency with YAC transgenics: behavioral and physical features. Hum Mol Genet. 2000;9(8):1145\u201359.","journal-title":"Hum Mol Genet"},{"key":"509_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2019.112068","volume":"372","author":"MA Toledo","year":"2019","unstructured":"Toledo MA, Wen TH, Binder DK, Ethell IM, Razak KA. Reversal of ultrasonic vocalization deficits in a mouse model of Fragile X Syndrome with minocycline treatment or genetic reduction of MMP-9. Behav Brain Res. 2019;372: 112068.","journal-title":"Behav Brain Res"},{"issue":"1","key":"509_CR41","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/S0306-4522(99)00285-7","volume":"94","author":"W Paradee","year":"1999","unstructured":"Paradee W, Melikian HE, Rasmussen DL, Kenneson A, Conn PJ, Warren ST. Fragile X mouse: strain effects of knockout phenotype and evidence suggesting deficient amygdala function. Neuroscience. 1999;94(1):185\u201392.","journal-title":"Neuroscience"},{"issue":"6","key":"509_CR42","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1111\/j.1601-183X.2004.00087.x","volume":"3","author":"QJ Yan","year":"2004","unstructured":"Yan QJ, Asafo-Adjei PK, Arnold HM, Brown RE, Bauchwitz RP. A phenotypic and molecular characterization of the fmr1-tm1Cgr fragile X mouse. Genes Brain Behav. 2004;3(6):337\u201359.","journal-title":"Genes Brain Behav"},{"issue":"1\u20132","key":"509_CR43","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0166-4328(00)00296-5","volume":"117","author":"D Van Dam","year":"2000","unstructured":"Van Dam D, D\u2019Hooge R, Hauben E, Reyniers E, Gantois I, Bakker CE, et al. Spatial learning, contextual fear conditioning and conditioned emotional response in Fmr1 knockout mice. Behav Brain Res. 2000;117(1\u20132):127\u201336.","journal-title":"Behav Brain Res"},{"issue":"3","key":"509_CR44","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.cell.2008.10.017","volume":"135","author":"RJ Kelleher 3rd","year":"2008","unstructured":"Kelleher RJ 3rd, Bear MF. The autistic neuron: troubled translation? Cell. 2008;135(3):401\u20136.","journal-title":"Cell"},{"key":"509_CR45","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aah6733","author":"A Selimbeyoglu","year":"2017","unstructured":"Selimbeyoglu A, Kim CK, Inoue M, Lee SY, Hong ASO, Kauvar I, et al. Modulation of prefrontal cortex excitation\/inhibition balance rescues social behavior in CNTNAP2-deficient mice. Sci Transl Med. 2017. https:\/\/doi.org\/10.1126\/scitranslmed.aah6733.","journal-title":"Sci Transl Med"},{"issue":"7363","key":"509_CR46","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/nature10360","volume":"477","author":"O Yizhar","year":"2011","unstructured":"Yizhar O, Fenno LE, Prigge M, Schneider F, Davidson TJ, O\u2019Shea DJ, et al. Neocortical excitation\/inhibition balance in information processing and social dysfunction. Nature. 2011;477(7363):171\u20138.","journal-title":"Nature"},{"issue":"7","key":"509_CR47","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1111\/j.1460-9568.1996.tb01615.x","volume":"8","author":"S Alcantara","year":"1996","unstructured":"Alcantara S, Soriano E, Ferrer I. Thalamic and basal forebrain afferents modulate the development of parvalbumin and calbindin D28k immunoreactivity in the barrel cortex of the rat. Eur J Neurosci. 1996;8(7):1522\u201334.","journal-title":"Eur J Neurosci"},{"issue":"3","key":"509_CR48","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1093\/cercor\/bhg132","volume":"14","author":"S Patz","year":"2004","unstructured":"Patz S, Grabert J, Gorba T, Wirth MJ, Wahle P. Parvalbumin expression in visual cortical interneurons depends on neuronal activity and TrkB ligands during an Early period of postnatal development. Cereb Cortex. 2004;14(3):342\u201351.","journal-title":"Cereb Cortex"},{"issue":"7","key":"509_CR49","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.tins.2004.04.009","volume":"27","author":"MF Bear","year":"2004","unstructured":"Bear MF, Huber KM, Warren ST. The mGluR theory of fragile X mental retardation. Trends Neurosci. 2004;27(7):370\u20137.","journal-title":"Trends Neurosci"},{"issue":"4","key":"509_CR50","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.neuron.2010.01.016","volume":"65","author":"C Luscher","year":"2010","unstructured":"Luscher C, Huber KM. Group 1 mGluR-dependent synaptic long-term depression: mechanisms and implications for circuitry and disease. Neuron. 2010;65(4):445\u201359.","journal-title":"Neuron"},{"issue":"1","key":"509_CR51","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/npp.2011.137","volume":"37","author":"C Gross","year":"2012","unstructured":"Gross C, Berry-Kravis EM, Bassell GJ. Therapeutic strategies in fragile X syndrome: dysregulated mGluR signaling and beyond. Neuropsychopharmacology. 2012;37(1):178\u201395.","journal-title":"Neuropsychopharmacology"},{"issue":"46","key":"509_CR52","doi-asserted-by":"publisher","first-page":"15616","DOI":"10.1523\/JNEUROSCI.3888-10.2010","volume":"30","author":"EK Osterweil","year":"2010","unstructured":"Osterweil EK, Krueger DD, Reinhold K, Bear MF. Hypersensitivity to mGluR5 and ERK1\/2 leads to excessive protein synthesis in the hippocampus of a mouse model of fragile X syndrome. J Neurosci. 2010;30(46):15616\u201327.","journal-title":"J Neurosci"},{"issue":"43","key":"509_CR53","doi-asserted-by":"publisher","first-page":"11624","DOI":"10.1523\/JNEUROSCI.2266-07.2007","volume":"27","author":"LJ Volk","year":"2007","unstructured":"Volk LJ, Pfeiffer BE, Gibson JR, Huber KM. Multiple Gq-coupled receptors converge on a common protein synthesis-dependent long-term depression that is affected in fragile X syndrome mental retardation. J Neurosci. 2007;27(43):11624\u201334.","journal-title":"J Neurosci"},{"issue":"5","key":"509_CR54","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1152\/jn.90752.2008","volume":"100","author":"JR Gibson","year":"2008","unstructured":"Gibson JR, Bartley AF, Hays SA, Huber KM. Imbalance of neocortical excitation and inhibition and altered UP states reflect network hyperexcitability in the mouse model of fragile X syndrome. J Neurophysiol. 2008;100(5):2615\u201326.","journal-title":"J Neurophysiol"},{"issue":"47","key":"509_CR55","doi-asserted-by":"publisher","first-page":"11298","DOI":"10.1523\/JNEUROSCI.2893-16.2017","volume":"37","author":"T Nomura","year":"2017","unstructured":"Nomura T, Musial TF, Marshall JJ, Zhu Y, Remmers CL, Xu J, et al. Delayed maturation of fast-spiking interneurons is rectified by activation of the TrkB receptor in the mouse model of Fragile X syndrome. J Neurosci. 2017;37(47):11298\u2013310.","journal-title":"J Neurosci"},{"issue":"6","key":"509_CR56","doi-asserted-by":"publisher","first-page":"2593","DOI":"10.1523\/JNEUROSCI.2447-12.2013","volume":"33","author":"AB Patel","year":"2013","unstructured":"Patel AB, Hays SA, Bureau I, Huber KM, Gibson JR. A target cell-specific role for presynaptic Fmr1 in regulating glutamate release onto neocortical fast-spiking inhibitory neurons. J Neurosci. 2013;33(6):2593\u2013604.","journal-title":"J Neurosci"},{"issue":"3","key":"509_CR57","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.neulet.2006.11.062","volume":"412","author":"L Selby","year":"2007","unstructured":"Selby L, Zhang C, Sun QQ. Major defects in neocortical GABAergic inhibitory circuits in mice lacking the fragile X mental retardation protein. Neurosci Lett. 2007;412(3):227\u201332.","journal-title":"Neurosci Lett"},{"issue":"10","key":"509_CR58","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1038\/s41593-018-0231-0","volume":"21","author":"A Goel","year":"2018","unstructured":"Goel A, Cantu DA, Guilfoyle J, Chaudhari GR, Newadkar A, Todisco B, et al. Impaired perceptual learning in a mouse model of Fragile X syndrome is mediated by parvalbumin neuron dysfunction and is reversible. Nat Neurosci. 2018;21(10):1404\u201311.","journal-title":"Nat Neurosci"},{"key":"509_CR59","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3389\/fncir.2018.00037","volume":"12","author":"BR Ferguson","year":"2018","unstructured":"Ferguson BR, Gao WJ. PV interneurons: critical regulators of E\/I balance for prefrontal cortex-dependent behavior and psychiatric disorders. Front Neural Circuits. 2018;12:37.","journal-title":"Front Neural Circuits"},{"issue":"2","key":"509_CR60","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/nrn3155","volume":"13","author":"O Marin","year":"2012","unstructured":"Marin O. Interneuron dysfunction in psychiatric disorders. Nat Rev Neurosci. 2012;13(2):107\u201320.","journal-title":"Nat Rev Neurosci"},{"key":"509_CR61","doi-asserted-by":"publisher","first-page":"3628","DOI":"10.1038\/ncomms4628","volume":"5","author":"L Ferron","year":"2014","unstructured":"Ferron L, Nieto-Rostro M, Cassidy JS, Dolphin AC. Fragile X mental retardation protein controls synaptic vesicle exocytosis by modulating N-type calcium channel density. Nat Commun. 2014;5:3628.","journal-title":"Nat Commun"},{"issue":"15","key":"509_CR62","doi-asserted-by":"publisher","first-page":"5693","DOI":"10.1523\/JNEUROSCI.6661-10.2011","volume":"31","author":"C Gross","year":"2011","unstructured":"Gross C, Yao X, Pong DL, Jeromin A, Bassell GJ. Fragile X mental retardation protein regulates protein expression and mRNA translation of the potassium channel Kv4.2. J Neurosci. 2011;31(15):5693\u20138.","journal-title":"J Neurosci"},{"issue":"4","key":"509_CR63","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.neuron.2012.12.018","volume":"77","author":"PY Deng","year":"2013","unstructured":"Deng PY, Rotman Z, Blundon JA, Cho Y, Cui J, Cavalli V, et al. FMRP regulates neurotransmitter release and synaptic information transmission by modulating action potential duration via BK channels. Neuron. 2013;77(4):696\u2013711.","journal-title":"Neuron"},{"issue":"44","key":"509_CR64","doi-asserted-by":"publisher","first-page":"15318","DOI":"10.1523\/JNEUROSCI.2162-12.2012","volume":"32","author":"Y Zhang","year":"2012","unstructured":"Zhang Y, Brown MR, Hyland C, Chen Y, Kronengold J, Fleming MR, et al. Regulation of neuronal excitability by interaction of fragile X mental retardation protein with slack potassium channels. J Neurosci. 2012;32(44):15318\u201327.","journal-title":"J Neurosci"},{"issue":"4","key":"509_CR65","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/S0092-8674(01)00568-2","volume":"107","author":"V Brown","year":"2001","unstructured":"Brown V, Jin P, Ceman S, Darnell JC, O\u2019Donnell WT, Tenenbaum SA, et al. Microarray identification of FMRP-associated brain mRNAs and altered mRNA translational profiles in fragile X syndrome. Cell. 2001;107(4):477\u201387.","journal-title":"Cell"},{"issue":"4","key":"509_CR66","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.neuron.2015.06.017","volume":"87","author":"A Contractor","year":"2015","unstructured":"Contractor A, Klyachko VA, Portera-Cailliau C. Altered Neuronal and Circuit Excitability in Fragile X Syndrome. Neuron. 2015;87(4):699\u2013715.","journal-title":"Neuron"},{"key":"509_CR67","doi-asserted-by":"publisher","first-page":"577525","DOI":"10.3389\/fncel.2020.577525","volume":"14","author":"F Filice","year":"2020","unstructured":"Filice F, Janickova L, Henzi T, Bilella A, Schwaller B. The Parvalbumin Hypothesis of Autism Spectrum Disorder. Front Cell Neurosci. 2020;14:577525.","journal-title":"Front Cell Neurosci"},{"issue":"2","key":"509_CR68","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1093\/cercor\/bhw349","volume":"28","author":"J Ariza","year":"2018","unstructured":"Ariza J, Rogers H, Hashemi E, Noctor SC, Martinez-Cerdeno V. The Number of Chandelier and Basket Cells Are Differentially Decreased in Prefrontal Cortex in Autism. Cereb Cortex. 2018;28(2):411\u201320.","journal-title":"Cereb Cortex"},{"issue":"2","key":"509_CR69","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1093\/cercor\/bhx063","volume":"28","author":"E Hashemi","year":"2018","unstructured":"Hashemi E, Ariza J, Rogers H, Noctor SC, Martinez-Cerdeno V. The Number of Parvalbumin-Expressing Interneurons Is Decreased in the Prefrontal Cortex in Autism. Cereb Cortex. 2018;28(2):690.","journal-title":"Cereb Cortex"},{"issue":"12","key":"509_CR70","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1038\/s41593-021-00967-6","volume":"24","author":"A Contractor","year":"2021","unstructured":"Contractor A, Ethell IM, Portera-Cailliau C. Cortical interneurons in autism. Nat Neurosci. 2021;24(12):1648\u201359.","journal-title":"Nat Neurosci"},{"issue":"4","key":"509_CR71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-018-0063-8","volume":"50","author":"O Babaev","year":"2018","unstructured":"Babaev O, Piletti Chatain C, Krueger-Burg D. Inhibition in the amygdala anxiety circuitry. Exp Mol Med. 2018;50(4):1\u201316.","journal-title":"Exp Mol Med"},{"issue":"5","key":"509_CR72","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1002\/ajmg.a.36468","volume":"164A","author":"VB Talisa","year":"2014","unstructured":"Talisa VB, Boyle L, Crafa D, Kaufmann WE. Autism and anxiety in males with fragile X syndrome: an exploratory analysis of neurobehavioral profiles from a parent survey. Am J Med Genet A. 2014;164A(5):1198\u2013203.","journal-title":"Am J Med Genet A"},{"issue":"5830","key":"509_CR73","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/293300a0","volume":"293","author":"MR Celio","year":"1981","unstructured":"Celio MR, Heizmann CW. Calcium-binding protein parvalbumin as a neuronal marker. Nature. 1981;293(5830):300\u20132.","journal-title":"Nature"},{"issue":"2","key":"509_CR74","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/BF00247904","volume":"76","author":"SH Hendry","year":"1989","unstructured":"Hendry SH, Jones EG, Emson PC, Lawson DE, Heizmann CW, Streit P. Two classes of cortical GABA neurons defined by differential calcium binding protein immunoreactivities. Exp Brain Res. 1989;76(2):467\u201372.","journal-title":"Exp Brain Res"},{"issue":"7","key":"509_CR75","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/nrn.2016.53","volume":"17","author":"J Urban-Ciecko","year":"2016","unstructured":"Urban-Ciecko J, Barth AL. Somatostatin-expressing neurons in cortical networks. Nat Rev Neurosci. 2016;17(7):401\u20139.","journal-title":"Nat Rev Neurosci"},{"issue":"6","key":"509_CR76","doi-asserted-by":"publisher","first-page":"e0198991","DOI":"10.1371\/journal.pone.0198991","volume":"13","author":"A Kisner","year":"2018","unstructured":"Kisner A, Slocomb JE, Sarsfield S, Zuccoli ML, Siemian J, Gupta JF, et al. Electrophysiological properties and projections of lateral hypothalamic parvalbumin positive neurons. PLoS ONE. 2018;13(6):e0198991.","journal-title":"PLoS ONE"},{"issue":"6242","key":"509_CR77","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1126\/science.aaa8694","volume":"348","author":"C Shang","year":"2015","unstructured":"Shang C, Liu Z, Chen Z, Shi Y, Wang Q, Liu S, et al. Brain circuits. A parvalbumin-positive excitatory visual pathway to trigger fear responses in mice. Science. 2015;348(6242):1472\u20137.","journal-title":"Science"}],"container-title":["Molecular Autism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13229-022-00509-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13229-022-00509-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13229-022-00509-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T12:04:16Z","timestamp":1656504256000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecularautism.biomedcentral.com\/articles\/10.1186\/s13229-022-00509-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,29]]},"references-count":77,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["509"],"URL":"https:\/\/doi.org\/10.1186\/s13229-022-00509-2","relation":{},"ISSN":["2040-2392"],"issn-type":[{"value":"2040-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,29]]},"assertion":[{"value":"7 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures involving mice were approved by New York University (NYU) Animal Care and Use Committee and followed the National Institutes of Health Guidelines for use of animals in research.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"29"}}